Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis, Moderate to Severe”

Showing 16 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05565560
What this trial is testing

Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 17
Testing effectiveness (Phase 2)Ended earlyNCT03358290
What this trial is testing

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque PsoriasisSkin Diseases
Akros Pharma Inc. 13
Large-scale testing (Phase 3)Study completedNCT00256139
What this trial is testing

CLEAR Study: Clinical Experience Acquired With Raptiva Study

Who this might be right for
Moderate to Severe Psoriasis
Merck KGaA, Darmstadt, Germany 793
Not applicableLooking for participantsNCT07582783
What this trial is testing

Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 200
Testing effectiveness (Phase 2)Study completedNCT02209753
What this trial is testing

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 182
Large-scale testing (Phase 3)Study completedNCT01722331
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 772
Post-approval studies (Phase 4)Study completedNCT01059773
What this trial is testing

A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

Who this might be right for
Psoriasis
Janssen-Cilag International NV 490
Large-scale testing (Phase 3)Study completedNCT05335356
What this trial is testing

Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Biocon Biologics UK Ltd 384
Testing effectiveness (Phase 2)Study completedNCT02407041
What this trial is testing

An Open-Label, Phase 2a Study to Evaluate Safety and Efficacy of GR-MD-02 for Treatment of Psoriasis

Who this might be right for
Psoriasis
Galectin Therapeutics Inc. 5
Post-approval studies (Phase 4)Study completedNCT05855967
What this trial is testing

Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India

Who this might be right for
Plaque PsoriasisPsoriatic Arthritis
Eli Lilly and Company 250
Early research (Phase 1)Study completedNCT00867100
What this trial is testing

Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 827

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 84
Large-scale testing (Phase 3)Study completedNCT01474512
What this trial is testing

Study in Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 1,296
Large-scale testing (Phase 3)Study completedNCT02203032
What this trial is testing

Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 872
Large-scale testing (Phase 3)Study completedNCT05377944
What this trial is testing

Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Bio-Thera Solutions 502
Large-scale testing (Phase 3)Study completedNCT03777436
What this trial is testing

An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis

Who this might be right for
Psoriasis
Amgen 289
Large-scale testing (Phase 3)Study completedNCT03482011
What this trial is testing

Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 530

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation